BDA advises Navis on the sale of majority stake in OPV Pharmaceuticals to RV Healthcare

has divested strategic stake to

divested majority stake in

to

acquired majority stake in

has been acquired by

received investment from

a subsidiary of

has acquired

a portfolio company of

has been acquired by

agreed to divest East Syracuse, New York facility to

has sold minority stake to

a portfolio company of

has been acquired by

investment from

has been acquired by

a portfolio company of

has been acquired by

agreed to divest Couvet, Switzerland facility to WuXi AppTec

raised Series B round from

backed by

has been acquired by

divested Escientia Life Sciences to Deccan Fine Chemicals